Comparison Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis
Comparison of Success Rate and Complication Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis in Cirrhotic Patients With Ascites
1 other identifier
interventional
80
1 country
1
Brief Summary
Comparison of success rate and complication between conventional angiocatheter versus new anchoring device (KARAHOC) used for paracentesis in cirrhotic patients with ascites.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2022
CompletedStudy Start
First participant enrolled
January 17, 2022
CompletedFirst Posted
Study publicly available on registry
October 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedOctober 13, 2022
October 1, 2022
12 months
January 16, 2022
October 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of success rate between conventional angiocatheter versus KARAHOC device used for paracentesis
The criterion for successful paracentesis is defined as drainage of 3L or more at an initial attempt.
through study completion, an average of 1 year
Secondary Outcomes (4)
comparison of complication rate
through study completion, an average of 1 year
operator satisfaction for each procedure
through study completion, an average of 1 year
patient satisfaction for each procedure
through study completion, an average of 1 year
Number of Participants with repeated paracentesis
through study completion, an average of 1 year
Study Arms (2)
KARAHOC group
EXPERIMENTALA group of patients in which paracentesis will be performed using a KARAHOC device.
conventional group
ACTIVE COMPARATORA group of patients in which paracentesis will be performed using an angiocatheter.
Interventions
After leaving a mark on the part where the puncture is to be performed using a pen, sterilization dressing are performed, local anesthesia is performed aseptic then ascites paracentesis by KARAHOC device.
After leaving a mark on the part where the puncture is to be performed using a pen, sterilization dressing are performed, local anesthesia is performed aseptic then ascites paracentesis by angiocatheter
Eligibility Criteria
You may qualify if:
- Adult over the age of 19
- Patients with pathological or clinical diagnosis of liver cirrhosis
- Patients with Grade 2 or higher grade of ascites as a complication due to portal hypertension
- Patients requiring periodic paracentesis
- Patients consent to this study
You may not qualify if:
- Patients with ascites due to peritoneal metastasis due to malignant tumor
- Patients with high bleeding risk (PT INR\>3, PLT\<30,000/mm3) difficult to perform ascites puncture
- Patients with hepatic encephalopathy or hepatorenal syndrome(HRS)
- Patients with severe cardiovascular disease, lung disease, or DIC
- Patients refusing paracentesis
- Patients who can control ascites using diuretics
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sang Gyune Kimlead
Study Sites (1)
Soon Chun Hyang University Bucheon Hospital
Bucheon-si, Gyeonggi-do, 14584, South Korea
Related Publications (6)
Iwakiri Y. Pathophysiology of portal hypertension. Clin Liver Dis. 2014 May;18(2):281-91. doi: 10.1016/j.cld.2013.12.001. Epub 2014 Feb 25.
PMID: 24679494BACKGROUNDMoore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut. 2006 Oct;55 Suppl 6(Suppl 6):vi1-12. doi: 10.1136/gut.2006.099580. No abstract available.
PMID: 16966752BACKGROUNDGentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M, La Villa G, Laffi G. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol. 1999 Apr;30(4):639-45. doi: 10.1016/s0168-8278(99)80194-9.
PMID: 10207805BACKGROUNDGines P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, Rimola A, Viver J, Camps J, Jimenez W, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology. 1987 Aug;93(2):234-41. doi: 10.1016/0016-5085(87)91007-9.
PMID: 3297907BACKGROUNDQuintero E, Gines P, Arroyo V, Rimola A, Bory F, Planas R, Viver J, Cabrera J, Rodes J. Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites. Lancet. 1985 Mar 16;1(8429):611-2. doi: 10.1016/s0140-6736(85)92147-6.
PMID: 2857949BACKGROUNDSalerno F, Badalamenti S, Incerti P, Tempini S, Restelli B, Bruno S, Bellati G, Roffi L. Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy. J Hepatol. 1987 Aug;5(1):102-8. doi: 10.1016/s0168-8278(87)80067-3.
PMID: 3655306BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sang gyune Kim, PhD
Soonchunhyang University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 16, 2022
First Posted
October 13, 2022
Study Start
January 17, 2022
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
October 13, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to make IPD available.